According to Australian media reports, after US President Trump has declared for several weeks that quinine (commonly known as cinchona), a drug used to treat malaria, is effective in preventing and treating new coronary pneumonia, the supply of quinine in the Australian medical market continues to be tight . On April 9, Dave Nicholls, President of the Australian Association of Rheumatology, issued a warning that patients desperately in need of medication faced the risk of no medicine being available.

At present, medical institutions in Australia and the United States are currently testing the efficacy of quinine in the treatment of new coronary pneumonia, and no effective basis has yet been found. Professor Nicholas was very angry at Trump’s approach to using Quinine as a “universal drug” for anti-epidemic medicine. He believes that Quinine is not the key to changing the situation of anti-epidemic medicine. Politicians must listen to the opinions of professionals and freely express their opinions.

Australian expert introduction: In addition to treating malaria, quinine can also be used to reduce inflammation caused by rheumatoid arthritis and lupus. A cancer patient in Brisbane complained that running three pharmacies in a row could not buy quinine. Many patients in Australia suffered from skin redness and joint pain due to lack of drugs, and severe cases also suffered liver and kidney damage. , Forced to be hospitalized. Due to the continued decline in national inventories, the Australian Medicines Agency has implemented a quinine purchase limit at the end of March and reminded patients not to use it blindly, paying attention to the serious side effects of the drug. Quinine is known to cause nausea, blurred vision and hallucinations.

(Original title Australia is caught in a quinine shortage Expert: Because Trump exaggerates the effect)